Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,104,171
+$2,608,680 QoQ
Shares Held
179,799
+5.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
4.13%
of 13F equity value
Holder Rank
#481
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stamos Capital Partners, L.P. holds $64,248,987 across 8 Drug Manufacturers - General names. MRK ranks #1 (36.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
179,799 | $23,104,171 | |
| 2 | JNJ |
Johnson & Johnson
|
43,175 | $10,965,154 | |
| 3 | NVO |
Novo Nordisk A S
|
184,608 | $8,850,107 | |
| 4 | PFE |
Pfizer Inc
|
297,285 | $7,158,622 | |
| 5 | LLY |
ELI LILLY & Co
|
5,449 | $6,535,694 | |
| 6 | GSK |
GSK plc
|
114,724 | $6,013,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,763 | $854,437 | |
| 8 | AMGN |
Amgen Inc
|
2,118 | $766,970 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,104,171 | 179,799 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,495,491 | 170,384 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,663,094 | 186,805 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,790,951 | 200,059 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,961,799 | 226,905 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,253,643 | 114,234 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,303,686 | 123,680 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,695,080 | 94,180 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,664,762 | 69,990 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,518,873 | 72,140 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,375,720 | 86,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,905,175 | 86,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,563,091 | 74,210 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,107,981 | 76,210 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,690,285 | 60,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,450,955 | 98,130 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,414,991 | 92,300 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,573,215 | 92,300 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,958,912 | 90,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,863,372 | 64,750 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,035,607 | 64,750 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,648,529 | 60,300 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,932,537 | 60,300 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,488,501 | 30,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,319,901 | 30,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,009,418 | 52,111 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||